Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GTCA: Gossypol with Docetaxel and Cisplatin in APE1-High NSCLC
NCT01977209Phase 3Unknown
- Sponsor
- Army Medical University
- Start
- Sep 2013
- Primary completion
- Feb 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of r-(-)-gossypol acetic acid in non-small cell lung cancer (NSCLC), sponsored by Army Medical University. Status: unknown.
02
Drugs
r-(-)-gossypol acetic acid
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01977209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01977209.